TrialFrontiers in immunology2025

Safety and immunogenicity of GamEvac-Combi, a heterologous rVSV- and rAd5-vectored Ebola vaccine: a randomized controlled multicenter clinical trial in the Republic of Guinea and Russia.

Denis Y Logunov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.